| Hunter Vauhn Steiner, MS, CCC-SLP | |
|
2703 University Blvd E, Tuscaloosa, AL 35404-3226 | |
| (205) 575-1609 | |
| Not Available |
| Full Name | Hunter Vauhn Steiner |
|---|---|
| Gender | Male |
| Speciality | Speech-language Pathologist |
| Location | 2703 University Blvd E, Tuscaloosa, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043820475 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Hunter Vauhn Steiner, MS, CCC-SLP 2703 University Blvd E, Tuscaloosa, AL 35404-3226 Ph: () - | Hunter Vauhn Steiner, MS, CCC-SLP 2703 University Blvd E, Tuscaloosa, AL 35404-3226 Ph: (205) 575-1609 |
News Archive
Prostate cancer is the second leading cause of cancer-related death among American men. Yet population-wide screening programs have not reduced the number of deaths from the disease. By focusing screening programs on the men who are at greatest risk for aggressive disease or diagnosis at a young age, researchers think they could improve mortality rates and personalize the screening approach.
United Therapeutics Corporation today announced its results of operations for the quarter ended March 31, 2010.
Medicaid is the largest funder of mental health services in the United States. In 2008, in all 50 states, Medicaid spent a total of $4.5 billion on behavioral health drugs, about a fifth of the $22.5 billion spent by the program on all pharmaceuticals combined. Roughly a third of the participants in Medicaid and the Children's Health Insurance Program experience a mental health episode annually, according to a 2010 report by the Mental Health Services Administration.
NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing therapeutics for rare gastrointestinal and endocrine disorders, today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that its New Drug Application (NDA) for Gattex (teduglutide) will be discussed at the Gastrointestinal Drugs Advisory Committee meeting scheduled for October 16, 2012.
Coronary artery bypass surgery provides long-term benefits for children whose hearts and blood vessels are damaged by Kawasaki disease, Japanese researchers report in Circulation: Journal of the American Heart Association.
› Verified 8 days ago
Michelle T Brown, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3701 Loop Rd, Tuscaloosa, AL 35404 Phone: 205-554-2000 | |
Kimberly Kirin, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8816 Old Greensboro Rd, Apt 3101, Tuscaloosa, AL 35405 Phone: 205-393-6907 | |
Laura Smith King, MS. CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4340 Evangeline Way, Tuscaloosa, AL 35406 Phone: 205-759-9374 | |
Mrs. Barbara Kawecki Wells, M.A.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1110 6th Ave E, Tuscaloosa, AL 35401 Phone: 205-759-1211 Fax: 205-722-1009 | |
Kelly Marie Dickey, SLPMSCCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 651 5th Ave E, Cdrc Rm 262, Tuscaloosa, AL 35401 Phone: 205-348-3130 Fax: 205-348-3157 | |
Elisa Colgrove, M.S., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 432 65th St Ste B, Tuscaloosa, AL 35405 Phone: 205-534-0128 |